Skip to main content
Premium Trial:

Request an Annual Quote

HTG Molecular EdgeSeq Pan B-Cell Lymphoma Panel

HTG Molecular Diagnostics has pre-launched its HTG EdgeSeq Pan B-Cell Lymphoma Panel, which the firm expects to offer as a kit or as a service for research use only use starting in July. The panel is designed to provide molecular characterization of aggressive lymphomas by allowing researchers to measure the expression of genes linked to the aggressive lymphoma transcriptome. The panel is an extension of HTG's DLBCL assay. 

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.